Incidence of nausea and vomiting in breast cancer patients treated with anthracycline plus cyclophosphamide-based chemotherapy regimens in Italy: NAVY observational study-Reference-Cited by-同舟云学术

Incidence of nausea and vomiting in breast cancer patients treated with anthracycline plus cyclophosphamide-based chemotherapy regimens in Italy: NAVY observational study

Published:2018-06-25 Issue:12 Volume:26 Page:4021-4029
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

De Laurentiis Michelino,Bonfadini Chiara,Lorusso Vito,Cilenti Giuseppina,Di Rella Francesca,Altavilla Giuseppe,Otero Manuela,Ardizzoia Antonio,Marchetti Paolo,Peverelli Giorgia,Amoroso Domenico,Vecchio Stefania,Fiorio Elena,Orecchia Simona

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/article/10.1007/s00520-018-4259-1/fulltext.html

Reference28 articles.

1. de Boer-Dennert M, de Wit R, Schmitz PI, Djontono J, v Beurden V, Stoter G, Verweij J (1997) Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists. Br J Cancer 76:1055–1061

2. Cohen L, de Moor CA, Eisenberg P, Ming EE, Hu H (2007) Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings. Support Care Cancer 15:497–503

3. Bloechl-Daum B, Deuson RR, Mavros P, Hansen M, Herrstedt J (2006) Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment. J Clin Oncol 24:4472–4478

4. Hesketh PJ (2008) Chemotherapy-induced nausea and vomiting. N Engl J Med 358:2482–2494

5. Feyer P, Jordan K (2011) Update and new trends in antiemetic therapy: the continuing need for novel therapies. Ann Oncol 22:30–38

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of chemotherapy-induced nausea and vomiting guideline adherence in pediatric and adult patients: a systematic review;Supportive Care in Cancer;2024-06-24

2. Palonosetron in pediatric patients: A single-center, retrospective evaluation of policy and clinical practice guideline discordance;Journal of Oncology Pharmacy Practice;2024-02-29

3. Netupitant/palonosetron (NEPA; Akynzeo®) combination in prevention of the nausea and vomiting in patients with breast cancer receiving anthracyclinbased chemotherapy;Tumors of female reproductive system;2023-10-27

4. Netupitant-palonosetron (NEPA) for Preventing Chemotherapy-induced Nausea and Vomiting: From Clinical Trials to Daily Practice;Current Cancer Drug Targets;2022-10

5. Dietary strategies for chemotherapy-induced nausea and vomiting: A systematic review;Clinical Nutrition;2022-10